BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 25951152)

  • 41. Time to first tumor progression as outcome predictor of a second trasuzumab-based therapy beyond progression in HER-2 positive metastatic breast cancer.
    Metro G; Giannarelli D; Gemma D; Lanzetta G; Ciccarese M; Papaldo P; Gamucci T; Lorusso V; Mottolese M; Magnolfi E; Cognetti F; Fabi A
    Breast J; 2010; 16(1):66-72. PubMed ID: 19889170
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The influence of ASCCP guideline changes on family medicine residency colposcopy training.
    Keehbauch J; Green L; Lugo N; Pepe J
    Fam Med; 2012 Oct; 44(9):650-3. PubMed ID: 23027158
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ASCCP patient management guidelines: Pap test specimen adequacy and quality indicators.
    Davey DD; Austin RM; Birdsong G; Buck HW; Cox JT; Darragh TM; Elgert PA; Hanson V; Henry MR; Waldman J;
    Am J Clin Pathol; 2002 Nov; 118(5):714-8. PubMed ID: 12428791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ASCCP Practice Guidelines: The Follow-Up System for Abnormal Cervical Cytological Findings.
    Cox JT
    J Low Genit Tract Dis; 1997 Jul; 1(3):167-70. PubMed ID: 25951023
    [No Abstract]   [Full Text] [Related]  

  • 45. Advanced Technologies in Cervical Cancer Screening ASCCP Biennial Meeting 1998.
    Cox JT; Herbst AL; Kinney W; Lorincz AT; Richart RM; Schiffman MH
    J Low Genit Tract Dis; 1999 Jan; 3(1 Suppl):S8. PubMed ID: 25950436
    [No Abstract]   [Full Text] [Related]  

  • 46. ASCCP Practice Guidelines Management Guidelines for the Follow-up of Cytology Read as Low Grade Squamous Intraepithelial Lesion.
    Cox TJ; Massad SL; Lonky N; Tosh R; Waxman A; Wilkinson EJ
    J Low Genit Tract Dis; 2000 Apr; 4(2):83-92. PubMed ID: 25950894
    [No Abstract]   [Full Text] [Related]  

  • 47. Atypical glandular cells: new Bethesda Terminology and Management Guidelines.
    Levine L; Lucci JA; Dinh TV
    Obstet Gynecol Surv; 2003 Jun; 58(6):399-406. PubMed ID: 12775944
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening.
    Wright TC; Schiffman M; Solomon D; Cox JT; Garcia F; Goldie S; Hatch K; Noller KL; Roach N; Runowicz C; Saslow D
    Obstet Gynecol; 2004 Feb; 103(2):304-9. PubMed ID: 14754700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The ASCCP, 2000 and Beyond.
    J Low Genit Tract Dis; 2000 Oct; 4(4):187-9. PubMed ID: 25951152
    [No Abstract]   [Full Text] [Related]  

  • 50. Guidelines for screening and treatment of cervical disease in the adolescent.
    Guido R
    J Pediatr Adolesc Gynecol; 2004 Oct; 17(5):303-11. PubMed ID: 15581775
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.